Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2019 1
2020 1
2021 1
2022 3
2023 1
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report.
van Schaik M, Arends EJ, Wetzels MJAL, Kraaij T, Verbruggen SH, van der Kooij SW, Kamerling SWA, Huizinga T, Goekoop RJ, van Kooten C, Rabelink T, Teng YKO. van Schaik M, et al. Among authors: arends ej. Lupus Sci Med. 2025 Feb 12;12(1):e001424. doi: 10.1136/lupus-2024-001424. Lupus Sci Med. 2025. PMID: 39939125 Free PMC article.
Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients.
Arends EJ, Meziyerh S, Moes DJAR, Kamerling SWA, van der Kooy S, Ogando NS, Snijder EJ, van Hemert M, Visser LG, Feltkamp MCW, Claas ECJ, Rabelink TJ, van Kooten C, de Vries APJ, Teng YKO. Arends EJ, et al. Kidney Int Rep. 2023 Sep 7;8(12):2654-2664. doi: 10.1016/j.ekir.2023.09.003. eCollection 2023 Dec. Kidney Int Rep. 2023. PMID: 38106593 Free PMC article.
Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.
van Schaik M, Arends EJ, Soonawala D, van Ommen E, de Leeuw K, Limper M, van Paassen P, Huizinga TWJ, Toes REM, van Kooten C, Rotmans JI, Rabelink TJ, Teng YKO. van Schaik M, et al. Among authors: arends ej. Trials. 2022 Nov 12;23(1):939. doi: 10.1186/s13063-022-06874-w. Trials. 2022. PMID: 36371234 Free PMC article.
Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients.
van Dam LS, Oskam JM, Kamerling SWA, Arends EJ, Bredewold OW, Berkowska MA, van Dongen JJM, Rabelink TJ, van Kooten C, Teng YKO. van Dam LS, et al. Among authors: arends ej. Front Immunol. 2020 Dec 15;11:566732. doi: 10.3389/fimmu.2020.566732. eCollection 2020. Front Immunol. 2020. PMID: 33384685 Free PMC article.
Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results.
Kraaij T, Arends EJ, van Dam LS, Kamerling SWA, van Daele PLA, Bredewold OW, Ray A, Bakker JA, Scherer HU, Huizinga TJW, Rabelink TJ, van Kooten C, Teng YKO. Kraaij T, et al. Among authors: arends ej. Nephrol Dial Transplant. 2021 Jul 23;36(8):1474-1483. doi: 10.1093/ndt/gfaa117. Nephrol Dial Transplant. 2021. PMID: 32591783 Free PMC article.
11 results